SKYTINIB 12.5 (Sunitinib Capsules 12.5 mg)

Manufacturer
Eugia Pharma Specialities Limited(INDIA)

Registraction Number
MAL24096045AZ

Content:

• Active Ingredient: Sunitinib Malate 12.5 mg
• Inactive Ingredients: Various excipients (binders, fillers, etc.)

• Advanced renal cell carcinoma, a type of kidney cancer that has spread to other parts of the body.
• Pancreatic neuroendocrine tumors (pNET), tumors of the hormone-producing cells in the pancreas that have progressed or cannot be removed with surgery.
• Advanced gastrointestinal stromal tumors (GIST), a type of stomach and bowel cancer.

• Dosage: The usual dose is 12.5 mg taken once daily, with or without food. The exact dose and duration of treatment should be determined by your doctor based on the type and severity of the cancer.
• Administration: Swallow the capsule whole with water. Do not crush or chew the capsule.
• Precautions: Inform your doctor if you have any allergies, liver or kidney problems, or if you are pregnant or planning to become pregnant. Avoid excessive alcohol consumption.
• Storage: Store at room temperature, away from moisture and heat.